Yi Larson
2020 - Turning Point Therapeutics
In 2020, Yi Larson earned a total compensation of $2.3M as Former Executive Vice President and Chief Financial Officer at Turning Point Therapeutics, a 82% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $255,600 |
|---|---|
| Option Awards | $1,434,883 |
| Salary | $451,688 |
| Other | $114,716 |
| Total | $2,256,887 |
Larson received $1.4M in option awards, accounting for 64% of the total pay in 2020.
Larson also received $255.6K in non-equity incentive plan, $451.7K in salary and $114.7K in other compensation.
Rankings
In 2020, Yi Larson's compensation ranked 4,989th out of 13,090 executives tracked by ExecPay. In other words, Larson earned more than 61.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,989 out of 13,090 | 62nd |
Division Manufacturing | 2,034 out of 5,621 | 64th |
Major group Chemicals And Allied Products | 809 out of 2,254 | 64th |
Industry group Drugs | 698 out of 1,954 | 64th |
Industry Pharmaceutical Preparations | 525 out of 1,459 | 64th |
Source: SEC filing on April 29, 2022.
Larson's colleagues
We found four more compensation records of executives who worked with Yi Larson at Turning Point Therapeutics in 2020.